Arbor Biotechnologies is a biotechnology company that discovers and engineers CRISPR and other gene‑editing systems for therapeutic applications. The company develops compact, high‑precision genome‑editing enzymes and delivery strategies to enable in vivo and ex vivo treatments for genetic diseases and other medical indications.
Leadership & Board
Current Number of Employees102
Current LinkedIn Followers16,250
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$74M
Total Amount Raised$74M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$74M
Latest Funding Amount$74M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Arbor Biotechnologies had 102 employees as of May 18, 2026. The number of employees decreased by 1 (0.97%) week-over-week.
102Latest Employee Count
1(-0.97%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Arbor Biotechnologies had 16,250 followers as of May 18, 2026. The number of followers increased by 50 (0.31%) week-over-week.
16,250Latest Followers Count
50(0.31%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Apr 18, 2025
Series C
$73.90M
―
Investors
Series C
Series C
